Isolated central nervous system lymphoid blast crisis in chronic myeloid leukaemia in major molecular remission.
Barlow
A
A
Department of Neuropathology, Southern General Hospital Glasgow, UK. antonia.barlow@sgh.scot.nhs.uk
Robertson
M
M
Doig
A
A
Stewart
W
W
Drummond
M W
MW
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D001752:Blast Crisis / Q000134:cerebrospinal fluid* / Q000188:drug therapy / Q000276:immunology; D002490:Central Nervous System / Q000276:immunology*; D000069439:Dasatinib; D006801:Humans; D000068877:Imatinib Mesylate; D016130:Immunophenotyping; D015466:Leukemia, Myeloid, Chronic-Phase / Q000134:cerebrospinal fluid* / Q000188:drug therapy / Q000276:immunology; D008297:Male; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D012074:Remission Induction; D013601:T-Lymphocytes / Q000276:immunology*; D013844:Thiazoles / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D013844:Thiazoles; D000068877:Imatinib Mesylate; D000069439:Dasatinib